Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H14N4O2 |
Molecular Weight | 258.2759 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[O-][N+](=O)C1=CC=C2N=C(C=CC2=C1)N3CCNCC3
InChI
InChIKey=GGDBEAVVGFNWIA-UHFFFAOYSA-N
InChI=1S/C13H14N4O2/c18-17(19)11-2-3-12-10(9-11)1-4-13(15-12)16-7-5-14-6-8-16/h1-4,9,14H,5-8H2
Molecular Formula | C13H14N4O2 |
Molecular Weight | 258.2759 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Du-24565 is a potent and selective inhibitor of the synaptosomal uptake of serotonin. At higher concentration, it affects the uptake of norepinephrine and dopamine. It is a potential antidepressant and can be useful as a pharmacological tool to study the role of 5-HT in the central nervous system. DU-24565 had little effect on serotonin or tyrosine accumulation in human melanoma cells but suppressed the uptake of extracellular Dopa. In vitro, DU-24565 inhibited the proliferation of PC-3, DU-145 and LNCaP human prostate carcinoma cells in a dose-dependent manner.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0051610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6973481 |
0.045 µM [IC50] | ||
Target ID: GO:0051620 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6973481 |
66.0 µM [IC50] | ||
Target ID: GO:0090494 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6973481 |
41.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of a fluorine-18-labelled derivative of 6-nitroquipazine, as a radioligand for the in vivo serotonin transporter imaging with PET. | 2002 Aug |
|
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter. | 2002 Dec 16 |
|
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines. | 2002 Mar 11 |
|
Biochemical evidence for the presence of serotonin transporters in the rat cochlea. | 2003 Aug |
|
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter: Part 3. A potential 5-HT transporter imaging agent, 3-(3-[18F]fluoropropyl)-6-nitroquipazine. | 2003 Nov 17 |
|
Zinc modulation of serotonin uptake in the adult rat corpus callosum. | 2005 Apr 1 |
|
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 4: 3-Alkyl-4-halo-6-nitroquipazines. | 2005 Aug 15 |
|
Extracellular protons differentially potentiate the responses of native AMPA receptor subtypes regulating neurotransmitter release. | 2005 Jan |
|
Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor. | 2005 Oct |
|
Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice. | 2006 Jun 15 |
|
Presynaptic modulation of 5-HT release in the rat septal region. | 2007 May 11 |
|
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 5: 2'-Substituted 6-nitroquipazines. | 2007 May 15 |
|
Synthesis and biological evaluation of one novel technetium-99m-labeled nitroquipazine derivative as an imaging agent for serotonin transporter. | 2008 Dec |
|
Effects of serotonergic agents on survival and hemolymph composition of the larval mosquito Aedes aegypti (Diptera: Culicidae, L.) in vivo: does serotonin regulate hemolymph acid-base homeostasis? | 2009 Nov |
|
Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands. | 2009 Oct 23 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6973481
Rat: 1 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6973481
DU-24565 at concentrations of 10(-8) and 10(-9) M was a potent inhibitor of serotonin uptake by rat blood platelets.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:46:40 UTC 2023
by
admin
on
Fri Dec 15 17:46:40 UTC 2023
|
Record UNII |
28M0X094BH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
28M0X094BH
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY | |||
|
5012
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY | |||
|
6-Nitroquipazine
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY | |||
|
77372-73-7
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY | |||
|
DTXSID7044001
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY | |||
|
C031227
Created by
admin on Fri Dec 15 17:46:40 UTC 2023 , Edited by admin on Fri Dec 15 17:46:40 UTC 2023
|
PRIMARY |